Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia
Background: Recent studies indicate the presence of mitochondrial dysfunction in brains of subjects with bipolar disorder (BD). Because the mitochondrial electron transport chain is a major source for production of reactive oxygen species that cause oxidative stress, we sought to determine in the p...
Saved in:
Published in | Bipolar disorders Vol. 11; no. 5; pp. 523 - 529 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: Recent studies indicate the presence of mitochondrial dysfunction in brains of subjects with bipolar disorder (BD). Because the mitochondrial electron transport chain is a major source for production of reactive oxygen species that cause oxidative stress, we sought to determine in the present study if BD is associated with oxidative stress.
Methods: Postmortem anterior cingulate brain sections from subjects with BD, major depressive disorder (MDD), or schizophrenia, and from nonpsychiatric, non‐neurologic comparison controls were generously provided by the Stanley Foundation Neuropathology Consortium. Oxidative stress was determined by analyzing 4‐hydroxynonenal (4‐HNE), a major product of lipid peroxidation. The level of 4‐HNE was determined by measuring 4‐HNE protein adducts using immunohistochemistry.
Results: We found that 4‐HNE levels were significantly increased by 59% in BD subjects and by 47% in schizophrenia subjects, but not in MDD subjects, when compared with controls. Levels of 4‐HNE were negatively correlated with pH in all 60 subjects. When pH was used as covariate, 4‐HNE levels were still significantly increased in BD subjects when compared with controls. Further, 4‐HNE levels were significantly correlated with pH values only in BD subjects, but not in MDD, schizophrenia, or control subjects.
Conclusions: Oxidative damage in the brain may contribute in part to the pathological process in BD and schizophrenia. This finding also suggests antioxidative stress as a probable alternative approach to the pharmacological treatment of these psychiatric disorders. |
---|---|
Bibliography: | istex:F28A497D55E354E5C2FBDEBC73D69DB67D544A4B ark:/67375/WNG-CP27F7KR-1 ArticleID:BDI717 The authors of this paper do not have any commercial associations that might pose a conflict of interest in connection with this manuscript. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 1398-5647 1399-5618 1399-5618 |
DOI: | 10.1111/j.1399-5618.2009.00717.x |